Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 22, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Laura Chico Reiterated (AVTE) at Buy and Held Target at $41 on, May 22nd, 2024
Laura Chico of Wedbush, Reiterated "Aerovate Therapeutics, Inc." (AVTE) at Buy and Held Target at $41 on, May 22nd, 2024.
Laura has made no other calls on AVTE in the last 4 months.
There are 2 other peers that have a rating on AVTE. Out of the 2 peers that are also analyzing AVTE, 0 agree with Laura's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Laura
- Tiago Fauth of "Wells Fargo" Maintained at Buy and Held Target at $35 on, Monday, April 1st, 2024
- Eun Yang of "Jefferies" Initiated at Strong Buy with Increased Target to $65 on, Monday, March 25th, 2024
